Recent publications on Cancer

Chao CR, Xu L, Wu BU, Figueiredo JC, Getahun D, Cannavale KL, Gilfillan AD, Chubak J Association between broad-spectrum antibiotic use and risk of early-onset colorectal cancer 2026 Apr;35(4):637-646 doi:10.1158/1055-9965.EPI-25-0912. doi: 10.1158/1055-9965.EPI-25-0912. Epub 2026-01-13. PubMed

Chubak J, Ichikawa L, Ziebell RA, Udaltsova N, Corley DA, Ghai NR, Lee JK, Halm EA, Skinner CS, Quesenberry C, Schottinger JE, Levin TR Positive predictive value of symptoms for early-onset colorectal cancer 2026 Mar 25 doi: 10.1158/1055-9965.EPI-25-0697. Epub 2026-03-25. PubMed

De Moor JS, Liang MI, Beauchemin MP, Glaser KM, Badr H, Yabroff KR, Fawzy Doran J, Majid A, Bell RA, Obeng-Gyasi S, Sampson A, Rhoades DA, Blinder V, Graves K, Park ER, Banegas MP, Pisu M, Kirchhoff AC, Wheeler SB, Rosenstein DL, Sadigh G, Edward JS, Bryant M, Jagsi R, Halpern M, You W, Nipp RD, Hershman DL, Henrikson NB Opportunities and Challenges for Addressing Financial Hardship as an Integrated Part of Cancer Care Delivery 2026 Mar 24 doi: 10.1093/jnci/djag077. Epub 2026-03-24. PubMed

Wang P, O'Connell K, Bhimani J, Blinder V, Burganowski R, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Roh JM, Tabatabai S, Valice E, Sampathkumar Y, Monroy-Iglesias MJ, Bandera EV, Kushi LH, Kantor ED, Aiello Bowles EJ Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings 2026 Mar 15;158(6):1481-1488 doi:10.1002/ijc.70266. doi: 10.1002/ijc.70266. Epub 2025-11-28. PubMed

Bhimani J, O'Connell K, Blinder VS, Burganowski R, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Jinna S, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Roh JM, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer 2026 Mar 15;132(6):e70318. doi: 10.1002/cncr.70318. PubMed

Sampathkumar Y, Zakaria Z, O'Connell K, Bhimani J, Blinder VS, Burganowski R, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Monroy-Iglesias MJ, Nakata KG, Persaud S, Roh JM, Tabatabai S, Valice E, Wang P, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer 2026 Mar 4 doi: 10.1093/jnci/djag063. Epub 2026-03-04. PubMed

Tosteson ANA, Stout NK, Su YR, van Ravesteyn NT, Lowry KP, Abraham L, Alagoz O, DiFlorio-Alexander R, de Koning HJ, Hampton JM, Henderson L, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, Trentham-Dietz A, Miglioretti DL, Kerlikowske K, Lee CI Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic Considerations 2026 Mar 3 doi: 10.7326/ANNALS-25-00792. Epub 2026-03-03. PubMed

Monroy-Iglesias MJ, O'Connell K, Bhimani J, Blinder VS, Burganowski-Doud RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Roh JM, Sampathkumar Y, Tabatabai S, Valice E, Wang P, Aiello Bowles EJ, Bandera EV, Kushi LH, Kantor ED Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer 2026 Mar;132(5):e70294. doi: 10.1002/cncr.70294. PubMed

Kessler LG, Comstock B, Aiello Bowles EJ, Mou J, Nash MG, Bravo P, Fleckenstein LE, Pflugeisen C, Gao H, Winer RL, Ornelas IJ, Smith C, Neslund-Dudas C, Shetty P, Raghavan UG Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening 2026 Feb 27 doi: 10.1093/aje/kwag040. Epub 2026-02-27. PubMed

Sprague BL, Gard CC, Chen S, Tice JA, Tosteson ANA, Perry H, Lee CI, Miglioretti DL, Kerlikowske K Advanced Versus Invasive Breast Cancer Risk in a Screening Population: Implications for Risk-based Prevention and Screening Strategies 2026 Feb 18 doi: 10.1007/s11606-026-10237-5. Epub 2026-02-18. PubMed

Pocobelli G, Del Vecchio NJ, Cushing-Haugen K, Kamineni A, Corley DA, Rendle KA, Halm EA, Li CI, Oshiro CES, Carroll NM, Silver MI, Greenlee RT, Neslund-Dudas C, Breslau ES, Chubak J Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening 2026 Feb 16 doi: 10.1093/jnci/djag044. Epub 2026-02-16. PubMed

Peoples AR, Obón-Santacana M, Kim AE, Kawaguchi ES, Fu Y, Qu C, Moratalla-Navarro F, Morrison J, Lin Y, Arndt V, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Conti DV, Corley DA, Devall MA, Dimou N, Drew DA, Gruber SB, Gunter MJ, Harlid S, Harrison TA, Hoffmeister M, Hsu L, Huyghe JR, Keku TO, Kundaje A, Lewinger JP, Li L, Lynch BM, Le Marchand L, Martín V, Murphy N, Newton CC, Ogino S, Hardikar S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Pellatt AJ, Pinchev M, Platz EA, Potter JD, Rennert G, Ruiz-Narvaez EA, Sakoda LC, Schoen RE, Shcherbina A, Stern MC, Su YR, Thomas CE, Tian Y, Tsilidis KK, Um CY, van Duijnhoven FJB, Van Guelpen B, Visvanathan K, Wang J, White E, Wolk A, Woods MO, Wu AH, Ulrich CM, Peters U, Gauderman WJ, Moreno V Genetic risk factors modulate the association between physical activity and colorectal cancer 2026 Feb 5;24(1) doi:10.1186/s12916-026-04675-5. doi: 10.1186/s12916-026-04675-5. Epub 2026-02-05. PubMed

Francis DO, Davies L, Zhang Y, Arroyo N, Fernandes-Taylor S, Nordby P, Cher BAY, Venkatesh M, Aiello Bowles EJ, Alagoz O Overdiagnosis of Papillary Thyroid Cancer 2026 Feb 2;9(2):e2559852. doi: 10.1001/jamanetworkopen.2025.59852. Epub 2026-02-02. PubMed

Mehta SJ, Shaw PA, Reitz C, Brophy C, Okorie E, Williams K, Segura A, Tao J, Snider CK, Wollack C, Friday S, Rendle KA, Klaiman T, Glanz K, Rhodes C, Asch DA Sequential choice vs colonoscopy outreach for colorectal cancer screening: Design and rationale of a pragmatic randomized clinical trial 2026 Feb;161:108188 doi:10.1016/j.cct.2025.108188. doi: 10.1016/j.cct.2025.108188. Epub 2025-12-16. PubMed

Clark CR, Lykken JM, Chen PM, Haas JS, Feldman S, Ahn C, Gu CA, Kobrin S, Silver MI, Atlas SJ, Chubak J, Tiro JA Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management Guidelines 2026 Feb;41(3):759-766 doi:10.1007/s11606-025-09611-6. doi: 10.1007/s11606-025-09611-6. Epub 2025-05-30. PubMed

Aiello Bowles EJ, O'Connell K, Bhimani J, Gallagher GB, Blinder VS, Doud RB, Ergas IJ, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Wang P, Bandera EV, Kushi LH, Kantor ED Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer 2026 Feb;118(2):307-315 doi:10.1093/jnci/djaf314. doi: 10.1093/jnci/djaf314. Epub 2025-11-03. PubMed

Wernli KJ, Anderson ML, Palazzo L, Luce C, Bezman N, Chin M, Gao H, Ralston JD, Rogers K, Su YR, Triplette M, Carter-Bawa L, Vasavada A, Jordan M, West M, Boler S, Green BB Effectiveness of health communication intervention to improve knowledge on timeliness to return for annual lung cancer screening: The Larch Trial 2026 Feb;169(2):550-561 doi:10.1016/j.chest.2025.07.4111. doi: 10.1016/j.chest.2025.07.4111. Epub 2025-09-10. PubMed

de Jonge L, Lansdorp-Vogelaar I, Doria-Rose VP, Portillo I, Novak Mlakar D, Buron A, Quintin C, Espinàs JA, Plaine J, Škrjanec AL, Kofol Bric T, Binefa G, Font R, Bulliard JL, Chubak J, Ziebell R, McCurdy BR, Rabeneck L, Senore C, International Cancer Screening Network Colorectal Cancer working group Global impact of COVID-19 on organized CRC screening programs: lessons learned 2026 Feb;80:102047. doi: 10.1016/j.bpg.2025.102047. Epub 2025-09-05. PubMed

Alagoz O, Lu Y, Gil Quessep E, Kerlikowske K, Mandelblatt JS, Sprague BL, Trentham-Dietz A, Hampton J, Groeneweg R, de Koning HJ, Miglioretti DL, Schechter CB, van Ravesteyn NT, Tosteson ANA, Stout NK, Lowry KP Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US 2026 Jan 2;9(1):e2552944. doi: 10.1001/jamanetworkopen.2025.52944. Epub 2026-01-02. PubMed

Veiga LHS, Gierach GL, Smith SA, Howell RM, Mille MM, Saha M, Curtis RE, Ramin C, Bodelon C, Feigelson HS, Aiello Bowles EJ, Buist DSM, Weinmann S, Vo JB, Lee C, Berrington de Gonzalez A Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors 2026 Jan;134(2):269-278 doi:10.1038/s41416-025-03240-w. doi: 10.1038/s41416-025-03240-w. Epub 2025-11-14. PubMed